These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 4325052)

  • 1. Papaverine-induced inhibition of phosphodiesterase activity in various mammalian tissues.
    Pöch G; Kukovetz WR
    Life Sci I; 1971 Feb; 10(3):133-44. PubMed ID: 4325052
    [No Abstract]   [Full Text] [Related]  

  • 2. Assay of phosphodiesterase with radioactively labeled cyclic 3',5'-AMP as substrate.
    Pöch G
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 268(3):272-99. PubMed ID: 4337726
    [No Abstract]   [Full Text] [Related]  

  • 3. Activation and inhibition of lipolysis in isolated fat cells by various inhibitors of cyclic AMP phosphodiesterase.
    Schwabe U; Berndt S; Ebert R
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 273(1):62-74. PubMed ID: 4338396
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the phosphodiesterase in various organs of rats and guinea-pigs of different ages and different sex.
    Petkov V; Stancheva S
    Acta Physiol Pharmacol Bulg; 1977; 3(1):38-45. PubMed ID: 197791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid hydrolysis of cyclic AMP as influenced by thyroid gland activity.
    Bastomsky CH; Zakarija M; McKenzie JM
    Biochim Biophys Acta; 1971 Feb; 230(2):286-95. PubMed ID: 4324761
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of phosphodiesterase inhibitors on cyclic AMP levels and on lipolysis.
    Beavo JA; Rogers NL; Crofford OB; Baird CE; Hardman JG; Sutherland EW; Newman EV
    Ann N Y Acad Sci; 1971 Dec; 185():129-36. PubMed ID: 4330487
    [No Abstract]   [Full Text] [Related]  

  • 7. Estimation of 5'-nucleotidase activity in nervous tissue.
    Pechán I; Turský T
    Enzymologia; 1969 Aug; 37(2):73-82. PubMed ID: 4309545
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition by papaverine and eupaverin of 3', 5'-cyclic AMP phosphodiesterase from rabbit skeletal muscle.
    Toson GC; Carpenedo F
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 273(1):168-71. PubMed ID: 4338394
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of the phosphodiesterases in the submaxillary gland, brain and liver.
    Bhoola KD; Lemon MJ
    Br J Pharmacol; 1972 May; 45(1):141P. PubMed ID: 4339390
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition by papaverine of 3',5'-nucleotide-phosphodiesterase (E.C.3.1.4.1.) from bovine uterus muscle.
    Rufeger U; Tellhelm B; Frimmer M
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 270(4):428-30. PubMed ID: 4328803
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclic phosphodiesterase activity and the action of papaverine.
    Triner L; Vulliemoz Y; Schwartz I; Nahas GG
    Biochem Biophys Res Commun; 1970 Jul; 40(1):64-9. PubMed ID: 4318586
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclic 3',5'-AMP phosphodiesterase in isolated fat cells. Simple and sensitive methods for the assay of phosphodiesterase activity in fat cells and studies of the enzyme inhibition by theophylline.
    Schönhöfer PS; Skidmore IF; Bourne HR; Krishna G
    Pharmacology; 1972; 7(2):65-77. PubMed ID: 4340944
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of dihydroergotamine on the phosphodiesterase activity of cat grey matter.
    Iwangoff P; Enz A
    Experientia; 1971; 27(11):1258-9. PubMed ID: 4332433
    [No Abstract]   [Full Text] [Related]  

  • 14. Activity of 3',5'-AMP phosphodiesterase in liver and adipose tissue of normal and diabetic rats.
    Müller-Oerlinghausen B; Schwabe U; Hasselblatt A; Schmidt FH
    Life Sci; 1968 Jun; 7(12):593-8. PubMed ID: 4299702
    [No Abstract]   [Full Text] [Related]  

  • 15. [Dissociation of function and metabolism of the isolated guinea pig heart under the influence of phosphodiesterase inhibitors].
    Klaus W; Krebs R; Seitz N
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 267(2):99-113. PubMed ID: 4320456
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of papaverine derivatives on cyclic AMP phosphodiesterase of human platelets.
    Markwardt F; Hoffmann A
    Biochem Pharmacol; 1970 Aug; 19(8):2519-20. PubMed ID: 4329211
    [No Abstract]   [Full Text] [Related]  

  • 17. Paper chromatography combined with phosphodiesterase treatment in the determination of radioactively labelled cyclic 3',5'-adenosine monophosphate.
    Osnes JB; Christoffersen T; Morland J; Oye I
    J Chromatogr; 1972 Apr; 67(1):139-47. PubMed ID: 4336978
    [No Abstract]   [Full Text] [Related]  

  • 18. [Guanyl cyclase. Biosynthesis of guanosine-3',5'-monophosphate in kidney and other rat tissues].
    Böhme E
    Eur J Biochem; 1970 Jul; 14(3):422-9. PubMed ID: 4320291
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of glucocorticoids on adenyl cyclase and phosphodiesterase activity in fat cell homogenates and the accumulation of cyclic AMP in intact fat cells.
    Schönhöfer PS; Skidmore IF; Paul MI; Ditzion BR; Pauk GL; Krishna G
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 273(3):267-82. PubMed ID: 4340199
    [No Abstract]   [Full Text] [Related]  

  • 20. Adenosine 3':5'-cyclic monophosphate phosphodiesterase in skin. I. Measurement and properties.
    Mier PD; Urselmann E
    Br J Dermatol; 1972 Feb; 86(2):141-6. PubMed ID: 4335966
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.